drugset / Trial / NCT06178783

A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants

NCT06178783

Phase 1 Completed 20 enrolled Insmed Incorporated
RandomizedCrossoverQuadruple-blindTreatment

Summary

The primary purpose of this study is to assess the palatability and compare acceptability of brensocatib oral solutions.

Timeline

Start
2023-12-27
Primary completion
2024-01-04
Completion
2024-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Brensocatib Small molecule Oral

Indications

No indication recorded.